Dallah Healthcare Company (4004.SR)
Saudi · SAR · Healthcare · Medical Care Facilities
SAR 64.35 (+3.79%) as of
Key statistics
- Market cap
- 7.84B
- P/E (TTM)
- 17.83
- Forward P/E
- 12.57
- EPS (TTM)
- 3.61
- Dividend yield
- 2.69%
- 52-week range
- 57.75 – 129.75
- Beta
- -0.47
- Revenue (TTM)
- 4.29B
- Profit margin
- 10.32%
- Analyst target
- SAR 103.97
- Volume
- 304.01k
About Dallah Healthcare Company
Dallah Healthcare Company operates as a health care company in the Kingdom of Saudi Arabia. The company engages in operating, managing, equipping, and developing hospitals and healthcare facilities, medical centres, complexes, and clinics; and the provision of manpower and support services. It also offers pharmaceuticals, cosmetics, consumables, equipment, and nutritional supplements, as well as medications, diagnostics, and medical technologies. In addition, the company provides personalized treatment plans, post-surgical recovery and chronic condition management, in-home nursing and physiotherapy, and teleconsultations and remote monitoring services. Further, it manages private hospitals, medical and diagnostic centers, and an analytical laboratory; and provides medical services. The company was formerly known as Dallah Healthcare Holding Company and changed its name to Dallah Healthcare Company in November 2016. The company was founded in 1987 and is based in Riyadh, Saudi Arabia.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Riyadh, Saudi Arabia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.